EndothelinA receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 42-49

  Mertz, Thomas E ^a   McClanahan, Thomas B ^a   Flynn, Michael A ^a   Juneau, Paul ^a   Reynolds, Elwood E ^a   Hallak, Hussein ^a   Bradford, Laura ^a   Gallagher, Kim P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; HEART INFARCTION; HEART INFARCTION SIZE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY VASCULAR RESISTANCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; SWINE;

ANIMALS; BINDING, COMPETITIVE; BLOOD PRESSURE; CORONARY VESSELS; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MYOCARDIAL INFARCTION; RECEPTORS, ENDOTHELIN; REPERFUSION; SWINE;

EID: 0030426652     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. AND NAKANISHI, S.: Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.) 348: 730-732, 1990.
2. B) mediate vasoconstriction in the perfused rat heart. J. Cardiovasc. Res. 22: Suppl. 8, S248-S251, 1993.
3. CIRINO, M., BATTISTINI, B., YANO, M. AND ROGER, I. W.: Dual cardiovascular effects of endothelin-1 dissociated by BQ-153, a novel ETA receptor antagonist. J. Cardiovasc. Pharmacol. 24: 587-594, 1994.
4. B receptor mediates both vasodilation and vasoconstriction in vivo. Boichem. Biophys. Res. Commun. 186: 867-873, 1992.
5. EZRA, D., GOLDSTEIN, R. E., CZAJA, J. F. AND FEUERSTEIN, G. Z.: Lethal ischemia due to intracoronary endothelin in pigs. Am. J. Physiol. 257: H339-H343, 1989.
6. 2. Br. J. Pharmacol. 112:963-971, 1994.
7. FRANCO-CERECEDA, A.: Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br. J. Pharmacol. 97: 968-972, 1989.
8. GROVER, G. J., DZWONCZYK, S. AND PARHAM, C. S.: The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc. Res. 27:1613-1618, 1993.
9. GROVER, G. J., SLEPH, P. G., Fox, M. AND TRIPPODO, N. C.: Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile func-tion and severity of ischemia in rat hearts. J. Pharmacol. Exp. Ther. 263: 1074-1082, 1992.
10. HIDE, E. J., PIPER, J., NEY, P., TIEMERMANN, C. AND VANE, J. R.: Endothelin-1 reduces infarct size in the rabbit by activating ATP-sensitive potassium channels (Abstract). Circulation 92: Suppl. 1, p. 1-455, 1995.
11. KRAUSE, S. M., LYNCH, J. J., JR., STABILITO, I.I. AND WOLTMANN, R. F.: Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischemic injury following acute coronary artery occlusion in the dog. Cardiovasc. Res. 28:1672-1678, 1994.
12. KURIHARA, H., YOSHIZUMI, M., SUGIYAMA, T., YAMAOKI, K., NAGAI, R., TAKAKU, F., SATOH, H., INUI, J., YANAGISAWA, M., MASAKI, T. AND YAZAKI, Y.: The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J. Cardiovasc. Pharmacol. 13: Suppl. 5, S132-S137, 1989.
13. KUSUMOTO, K., AWANE, Y., FUJIWARA, S. AND WATANABE, T.: Role of endothelin in extension of rabbit myocardial infarction. J. Cardiovasc. Pharmacol. 22: Suppl.8, S339-S342, 1993.
14. A receptor antagonist, FR139317, on infarct size in a rabbit model of acute myocardial ischemia and reperfusion. Br. J. Pharmacol. 112: 75-80, 1994.
15. NETER, J. AND WASSERMAN, W.: Applied Linear Statistical Models; Regression, Analysis of Variance, and Experimental Designs, pp. 160-165, Richard D. Irwin, Inc., Home wood, IL, 1974.
16. OMLAND, T., LIE, T. J., AAKVAAG, A., AARSLAND, T. AND DICKSTEIN, K.: Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89:1573-1579, 1994.
17. A receptor antagonist. J. Pharmacol. Exp. Ther. 273:1410-1417, 1995.
18. RICHARD, V., KAEFFER, N., HOGIE, M., TRON, C., BLANC, T. AND THUILLEZ, C.: Role of endogenous endothelin in myocardial and coronary endothelial injury after ischemia and reperfusion in rats: Studies with bosentan, a mixed ETA-ETB antagonist. Br. J. Pharmacol. 113: 869-876, 1994.
19. RIGEL, D. F. AND LAPPE, R. W.: Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J. Cardiovasc. Pharmacol. 22: Suppl. 8, S243-S247, 1993.
20. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. AND MASAKI, T.: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (Lond.) 348: 732-735, 1990.
21. SAVAGE, R. M., GUTH, B., WHITE, F. C., HAGAN, A. D. AND BLOOR, C. M.: Correlation of regional myocardial blood flow and function with infarct size during acute ischemia in the conscious pig. Circulation 64: 699-707, 1981.
22. SCHAPER, W.: Residual perfusion of acutely ischemic heart muscle. In The Pathophysiology of Myocardial Perfusion, ed. by W. Schaper, pp. 345-378, Elsevier-North-Holland Biomedical Press, Amsterdam, 1979.
23. SEO, B., OEMAR, B. S., SIEBENMANN, R., SEGESSER, L. V. AND LUSCHER, T. F.: Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994.
24. STAWSKI, G., BANG OLSEN, U. AND GRANDE, P.: Cytotoxic effect of endothelin-1 during "simulated" ischemia in cultured rat myocytes. Eur. J. Pharmacol. 201: 123-124, 1991.
25. STEWART, D. J., KUBAC, G., COSTELLO, K. B. AND CEHNACEK, P.: Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18: 38-43, 1991.
26. B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107: 858-860, 1992.
27. TEERLINK, J. R., BREU, V., SPRECHER, U., CLOZEL, M. AND CLOZEL, J.-P.: Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ. Res. 74: 105-114, 1994.
28. TONNESSEN, T., NAESS, P. A., KIRKEBOEN, K. A., OFFSTAD, J., ILEBEKK, A. AND CHRISTENSEN, G.: Endothelin is released from the porcine coronary circulation after short-term ischemia. J. Cardiovasc. Pharmacol. 22: Suppl. 8, S313-S316, 1993.
29. TOYO-OKA, T., AIZAWA, T., SUZUKI, N., HIRATA, Y., MIYAUCHI, T., SHIN, W. S., YANAGISAWA, M., MASAKI, T. AND SUGIMOTO, T.: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483, 1991.
30. TUKEY, J. W., CIMINERA, J. L. AND HEYSE, J. F.: Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41: 295-301, 1985.
31. VELASCO, C. E., YANAGISAWA, M., WILLIAMSON, J. L. AND TRIANA, J. F.: Cardioprotective action of endothelin-1 during ischemia (Abstract). Circulation 88: p. 1-544, 1993.
32. VITOLA, J. V., HOLSINGER, J. P., ATKINSON, J. B., JACKSON, E. K., FOKMAN, M. B. AND MURRAY, J. J.: Endothelin antagonists prevent hemodynamic changes, arrhythmias and death with infused endothelin but do not modify myocardial salvage in a reperfusion injury model (Abstract). Circulation 90: 1-35, 1994.
33. WANG, P., GALLAGHER, K., DOWNEY, J. A. AND COHEN, M. V.: Endothelin-1 limits myocardial infarction through PKC activation. J. Mol. Cell Cardiol. 28: 579-588, 1996.
34. WANG, Q-D., Li, X.-S., LUNDBERC, J. M. AND PERNOW, J.: Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischemia and reperfusion injury in the pig. Cardiovasc. Res. 29: 805-812, 1995.
35. WARNER, T. D., ALLCOCK, G. H., MICKLEY, E. J., CORDER, R. AND VANE, J. R.: Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J. Cardiovasc. Pharmacol. 22: Suppl.8, S117-S120, 1993.
36. B receptor antagonist, TAK-044, and the inhibition of myocardial infarct size in rats. Br. J. Pharmacol. 114: 949-954, 1995.
37. WATANABE, T., AWANE, Y., IKEDA, S., FUJIWARA, S., WAKIMASU, M. AND FUJINO, M.: An endothelin receptor antagonist, TAK-044, limits the extension of myocardial infarct size in rats. Jpn. J. Pharmacol. 64: Suppl. I, 261P, 1994.
38. WATANABE, T., SUZUKI, N., SHIMAMOTO, N., FUJINO, M. AND IMADA, A.: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ. Res. 69: 370-377, 1991.
39. YASUDA, M., KOHNO, M., TAHARA, A., ITAGANE, H., TODA, I., AKIOKA, K., TERAGAKI, M., OKU, H., TAKEUCHI, K. AND TAKEDA, T.: Circulating immunoreactive endothelin in ischemic heart disease. Am. Heart J. 119: 801-806, 1990.